THE VALUE AGENDA FOR THE NETHERLANDS – A CALL FOR ACTION

The Netherlands could become a leader in the field of Value-Based Health Care”, states Harvard Professor Michael Porter. During a working session held in Nijkerk on May 11, key challenges for large-scale implementation of Value-Based Health Care (VBHC) were identified and discussed by twenty-five decision makers in health care from the Netherlands.

This working session was organized by The Decision Group, Amgen and Medtronic to ‘call for action’ and formulate the key actions to collaboratively accelerate VBHC implementation in the Netherlands and improve value for patients.

Are you interested in the final report and/or sharing your thoughts about the Value Agenda?

Please contact us via info@thedecisiongroup.nl for more information.

Click here to see the full report of the Value Agenda for The Netherlands 2017
Click here to see the Summary Statement of the Value Agenda for The Netherlands 2017
Logo Medtronic GOED
TDG_web200px-1
Amgen logo transp van internet

Stay up to date on the latest VBHC insights!

Subscribe below to stay up to date on education by The Decision Institute:




Join the community!

Click here for more information

VBHC CE 2